Macfarlanes advised Signal Capital Partners on the deal. Signal Capital Partners, a leading private asset management firm focused on private credit solutions for European corporate and...
You must be a Standard 1 Year member to access this content.
Macfarlanes has advised Volpi Capital LLP. Volpi Capital LLP, a specialist European lower mid-market private equity firm, establishmed and closed Volpi Capital Investments Conti LP. The new continuation...
You must be a Standard 1 Year member to access this content.
Macfarlanes has advised UK-based private equity firm Synova. The new fund, which reached its cap in only three months, will continue Synova’s investment strategy of investing...
You must be a Standard 1 Year member to access this content.
Macfarlanes and Pinsent Masons advised Northern Gritstone on the deal. Northern Gritstone, a new investment business focused on university spinouts in the north of England, raised...
You must be a Standard 1 Year member to access this content.
Macfarlanes and Trowers & Hamlins advised property investment firm Apache Capital Partners on the deal. Apache Capital Partners established a joint venture with KKR to create...
You must be a Standard 1 Year member to access this content.
Macfarlanes has advised Tembo Capital Management on the deal. Tembo Capital Management, a leading investment advisor in the metals and mining sector, on its third fund,...
You must be a Standard 1 Year member to access this content.
Macfarlanes has advised 17Capital on its fifth fund, 17Capital Fund 5, which has successfully held a final closing at its hard cap. The fund provides preferred...
You must be a Standard 1 Year member to access this content.
Macfarlanes advised Signal Capital Partners on the fundraising. The Signal Alpha II fund, which is one of the largest dedicated special situations funds in Europe, exceeded its...
You must be a Standard 1 Year member to access this content.
Macfarlanes has advised Advent Life Sciences on the transaction. Advent Life Sciences raised two new life sciences-focused funds, Advent Life Sciences Fund III and the Advent-Harrington Impact...
You must be a Standard 1 Year member to access this content.
